Study guide
5.4 Pain Management in Labour: Non-Pharmacological & Pharmacological Analgesia
NMC Test of Competence Part 1: Midwifery Computer-Based Test Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: NMC Framework, Autonomy & Professional Ethics
1.1 NMC Regulatory Architecture, RM Registration & The Code 1.2 Autonomous Midwifery Practice, Accountability & Delegation 1.3 Informed Consent, Capacity, Advocacy & Human Rights 1.4 Duty of Candour, Confidentiality & Clinical Documentation Human Rights, Equality, Anti-Discriminatory & Culturally Sensitive Care
2 Chapter 2: Continuity, Public Health & Perinatal Mental Health
2.1 Continuity of Carer & Physiological Midwifery Care 2.2 Public Health, Social Determinants & Health Inequalities 2.3 Perinatal Mental Health Assessment & Emergency Psychiatric Care UK Health & Social Care System, Birth Settings, Safe Staffing & Keeping Mothers and Babies Together
3 Chapter 3: Safeguarding, Vulnerable Populations & FGM
3.1 Safeguarding Children & Adults at Risk in Maternity Care 3.2 Domestic Abuse Identification, Risk Assessment & Multi-Agency Referral 3.3 FGM Mandatory Reporting, Clinical Classification & Trauma-Informed Practice
4 Chapter 4: Universal Antenatal Care & Fetal Assessment
4.1 Antenatal Care Schedule, Physiological Adaptations & Routine Investigations 4.2 Fetal Growth Surveillance, Fundal Height & Symphysis-Fundal Height (SFH) Plotting 4.3 UK National Screening Committee (UK NSC) Antenatal Screening Programmes 4.4 Antenatal Education, Birth Planning & Minor Disorders of Pregnancy Reproductive Anatomy, Genetics & Genomics, Embryology and Fetal Development
5 Chapter 5: Universal Intrapartum Care & Physiological Labour
5.1 Physiology of Normal Labour, Hormonal Regulation & Latent vs Active First Stage 5.2 Second Stage Management, Mechanisms of Normal Labour & Perineal Protection 5.3 Third Stage Management: Active vs Physiological & Examination of Placenta/Membranes 5.4 Pain Management in Labour: Non-Pharmacological & Pharmacological Analgesia
6 Chapter 6: Universal Postnatal Care & Infant Feeding
6.1 Physiological Maternal Postnatal Involution, Assessment & Recovery 6.2 Perineal Trauma Assessment, Classification (1st to 4th Degree) & Care Principles 6.3 Physiology of Lactation, Breastfeeding Support & UNICEF Baby Friendly Standards 6.4 Formula Feeding Safety, Responsive Bottle Feeding & Infant Growth Patterns Contraception & Sexual and Reproductive Health after Birth
7 Chapter 7: Newborn Assessment & Neonatal Care
7.1 Newborn Transition, Apgar Scoring, Thermoregulation & Skin-to-Skin Care 7.2 Newborn Physical Examination (NIPE 4 Core Elements) & Routine Prophylaxis 7.3 Neonatal Blood Spot Screening, Hearing Screening & Infection Prevention
8 Chapter 8: Medical & Obstetric Antenatal Complications
8.1 Pre-existing Medical Conditions in Pregnancy (Diabetes, Cardiac, Epilepsy, Renal) 8.2 Hypertensive Disorders of Pregnancy, Pre-eclampsia & Eclampsia 8.3 Antepartum Haemorrhage: Placenta Praevia, Placental Abruption & Vasa Praevia 8.4 Gestational Diabetes Mellitus (GDM): Screening, Diagnostic Criteria & Management
9 Chapter 9: Intrapartum Complications & Obstetric Emergencies
9.1 Postpartum Haemorrhage (PPH): Definition, 4Ts, Bimanual Compression & Medical Protocols 9.2 Shoulder Dystocia: Recognition, Risk Factors & HELPERR Emergency Sequence 9.3 Umbilical Cord Prolapse, Uterine Rupture & Amniotic Fluid Embolism 9.4 Maternal Sepsis, MEOWS Escalation & Maternal Resuscitation (Modified BLS/ALS)
10 Chapter 10: Fetal Compromise & Neonatal Complications
10.1 Intrapartum Fetal Heart Rate Monitoring & CTG Interpretation (NICE / FIGO) 10.2 Neonatal Resuscitation: Resuscitation Council UK NLS Algorithm 10.3 Neonatal Hypoglycaemia, Hyperbilirubinaemia & Neonatal Sepsis (NICE NG195) 10.4 Perinatal Loss, Bereavement Care & Perinatal Palliative Support
11 Chapter 11: Midwifery Pharmacology, Prescribing & Skills
11.1 Midwives Exemptions under Human Medicines Regulations 2012 & PGDs 11.2 Core Midwifery Medicines Administration & Controlled Drugs Storage/Recording 11.3 Episiotomy: Clinical Indications, Infiltration Technique & Incision Anatomy 11.4 Aseptic Non-Touch Technique (ANTT), Bladder Catheterisation & Cannulation Infection Prevention & Control, Communicable Disease Surveillance and Antimicrobial Stewardship
12 Chapter 12: Leadership, Multidisciplinary Safety & Quality
12.1 Interprofessional Team Communication, SBAR Handover & Human Factors 12.2 Incident Reporting, Root Cause Analysis & Learning from Reviews (MNSI, MBRRACE) 12.3 Midwife as Scholar, Clinical Supervisor, Leader & Escalating Safety Concerns Research Methods, Critical Appraisal, Audit & Service Evaluation Quality Improvement, Change Management, Sustainable Healthcare & Digital Practice Resilience, Wellbeing, Reflection, Human Factors & Leading Care
13 Chapter 13: Part A Numeracy & Drug Calculation Mastery
13.1 Metric Units, Conversions, Rounding & CBT Pearson VUE Numeric Answer Rules 13.2 Oral Medications, Liquid Suspensions & Solid Dose Calculations 13.3 Injectable Medicines, Dilutions, Percentages & Weight-Based Calculations 13.4 Intravenous Infusions, Flow Rates, Syntocinon/Oxytocin & Magnesium Sulfate Protocols
5.4 Pain Management in Labour: Non-Pharmacological & Pharmacological Analgesia
Key Takeaways Explain This Topic AI
Labour pain transitions neurologically from visceral pain mediated by T10-L1 sympathetic afferents in the first stage to somatic pain mediated by S2-S4 pudendal nerves in the second stage.
Continuous one-to-one support, a calm birth environment and water immersion (≤37.5°C) aid coping; NICE notes very little evidence that TENS works in established labour.
Entonox (50:50 nitrous oxide and oxygen) is an effective, short-acting self-administered inhalational analgesic; inhalation must begin 20-30 seconds prior to contraction peak to align with the acme.
Systemic intramuscular opioids (diamorphine 5-10 mg or pethidine 50-100 mg with cyclizine) cross the placenta, causing maternal sedation/nausea and neonatal respiratory depression or reduced CTG variability; neonatal naloxone must be immediately available.
NICE advises IV access before an epidural, BP every 5 minutes for 15 minutes after establishment and each 10 mL bolus, and continuous CTG once regional analgesia is inserted.
Last updated: October 2026
Pain Management in Labour: Non-Pharmacological & Pharmacological Analgesia
Labour pain is a complex, subjective, multidimensional physiological experience shaped by neurobiological, emotional, cultural, and environmental factors. Unlike pathological pain, which signals tissue injury or disease, physiological labour pain is a functional, adaptive biological process that guides maternal posture, stimulates endogenous neuroendocrine cascades, and facilitates birth. The midwife's role is not to impose analgesia, but to support the woman's informed choice, optimize physiological coping, and provide safe, evidence-based pharmacological interventions when desired or indicated.
Neurophysiology and Pathways of Labour Pain
The anatomical origin and transmission pathways of labour pain change fundamentally as labour transitions from the first stage to the second stage. NEUROLOGICAL DUAL PATHWAYS OF LABOUR PAIN
- ┌───────────────────────────────────┬───────────────────────────────────┐
- │ FIRST STAGE: VISCERAL PAIN │ SECOND STAGE: SOMATIC PAIN │
- ├───────────────────────────────────┼───────────────────────────────────┤
- │ • Mechanical cervical dilatation │ • Distension of pelvic floor │
- │ • Myometrial cellular ischemia │ • Stretching of vagina & perineum │
- │ • Lower uterine segment distension│ • Direct nerve compression │
- │ • Transmitted by SYMPATHETIC │ • Transmitted by SOMATIC │
- │ visceral afferents (T10 - L1) │ pudendal nerve fibres (S2 - S4) │
- │ • Diffuse, aching, poorly local │ • Sharp, localized, intense │
- │ • Referred to abdomen, groin, back│ • Localized to introitus & rectum │
- └───────────────────────────────────┴───────────────────────────────────┘
- 1. First Stage: Visceral Pain (T10 to L1)
During the first stage of labour, nociceptive impulses originate primarily from:
- Mechanical stretching and distension of the cervix during effacement and dilatation;
- Mechanical distension of the lower uterine segment; and
Ischemia of myometrial smooth muscle myocytes during contractions, caused by local arteriole compression.
These visceral nociceptors generate slow, unmyelinated C-fibre and lightly myelinated A-delta fibre impulses that accompany sympathetic nerve trunks through the inferior, middle, and superior hypogastric plexuses. They traverse the lumbar and lower thoracic sympathetic chain and enter the dorsal horn of the spinal cord at the T10, T11, T12, and L1 spinal segments .
Because visceral afferents converge with somatic dermatomal afferents in the dorsal horn, first-stage pain is characteristically diffuse, cramping, and referred . Pain is perceived along the dermatomes corresponding to T10-L1: across the lower abdominal wall, the lumbosacral region, the iliac crests, and the anterior upper thighs.
2. Second Stage: Somatic Pain (S2 to S4)
In the second stage of labour, uterine contractions continue, but the primary source of pain shifts to the mechanical descent of the presenting part:
- Marked distension, stretching, and microtrauma of the pelvic floor musculature (levator ani complex);
- Extreme stretching of the vaginal vault, vulval introitus, and perineal body; and
Direct compression of pelvic somatic structures and the rectum.
These sensory nociceptive impulses are transmitted via heavily myelinated, rapid somatic sensory nerve fibres within the pudendal nerve , which enters the spinal cord at sacral segments S2, S3, and S4 .
Unlike visceral pain, somatic pain is sharp, intense, lancinating, and exquisitely well-localized to the perineum, rectum, and vagina. Somatic pain triggers the involuntary maternal bearing-down urge (Ferguson reflex) as the fetal head exerts direct mechanical pressure on the pelvic floor.
Non-Pharmacological Comfort Measures
Non-pharmacological pain strategies support physiological birth by activating descending endogenous inhibitory pathways, reducing maternal anxiety, and preventing excess catecholamine secretion.
Continuous One-to-One Midwifery Support
Large Cochrane systematic reviews (e.g., Hodnett et al.) establish that continuous one-to-one emotional and physical support from a midwife or trained birth companion is one of the most effective intrapartum interventions in modern maternity care:
- Significant reduction in the use of regional epidural and systemic opioid analgesia;
- Shortened duration of labour;
- Statistically significant reduction in instrumental deliveries and emergency caesarean births;
- Lower rates of low 5-minute Apgar scores; and
Substantially higher rates of maternal satisfaction and psychological well-being.
Birth Environment Optimization
The intrapartum environment profoundly affects maternal neuroendocrinology. Exposure to bright lights, loud noises, unfamiliar clinical equipment, or unannounced interruptions activates the maternal sympathetic nervous system, precipitating a "fight-or-flight" adrenaline and noradrenaline surge . High circulating catecholamines:
- Inhibit hypothalamic oxytocin pulsatility, slowing or arresting labour progress;
- Cause peripheral and uteroplacental vasoconstriction, reducing fetal oxygenation; and
Amplify fear and pain perception.
Midwives optimize the birth space by dimming lights, ensuring warmth, minimizing ambient noise, maintaining continuous privacy, and speaking in calm, reassuring tones, thereby promoting parasympathetic dominance, endogenous oxytocin release, and beta-endorphin secretion.
Hydrotherapy and Warm Water Immersion
Immersing in a deep birth pool during the active first stage provides substantial physiological and psychological benefits:
Thermal Effect : Warm water promotes generalized vasodilation, reduces arterial blood pressure, and induces deep muscular relaxation.
Buoyancy : Buoyancy reduces gravitational forces on the maternal pelvis, relieves axial pressure on the spine and joints, and allows effortless maternal postural changes.
Analgesic Efficacy : Water immersion significantly reduces maternal perception of contraction pain and substantially reduces uptake of regional epidural analgesia.
Water Temperature Standard : Midwives must monitor and record water temperature hourly, ensuring it is maintained at or below 37.5°C . Excessive water temperature (>37.5°C) leads to maternal pyrexia, which causes maternal dehydration, fetal hyperthermia, and persistent fetal tachycardia on auscultation.
Transcutaneous Electrical Nerve Stimulation (TENS)
TENS units are handheld, battery-powered devices delivering pulsed electrical currents through four adhesive dermal electrodes applied to the maternal back. TENS ELECTRODE ANATOMICAL PLACEMENT
- ┌─────────────────────────┐
- │ SPINAL CORD │
- └────────────┬────────────┘
- │
- ┌──────────────────────────┴──────────────────────────┐
- ▼ ▼
- ┌────────────────────────────────┐ ┌────────────────────────────────┐
- │ UPPER PAIR (T10 - L1) │ │ LOWER PAIR (S2 - S4) │
- │ • Applied paravertebrally over │ │ • Applied over the sacrum │
- │ lower thoracic / upper lumbar│ │ above the natal cleft │
- │ • Modulates first-stage │ │ • Modulates second-stage │
- │ visceral uterine afferents │ │ somatic pelvic afferents │
- └────────────────────────────────┘ └────────────────────────────────┘
- Mechanism of Action
Gate Control Theory of Pain (Melzack & Wall) : TENS delivers non-noxious electrical stimulation that excites large-diameter, myelinated A-beta sensory nerve fibres . In the substantia gelatinosa of the spinal dorsal horn, these A-beta inputs activate inhibitory interneurons, effectively "closing the presynaptic neural gate" and blocking the upward transmission of slow, unmyelinated C-fibres carrying visceral contraction pain.
Endorphin Release : Low-frequency pulsed currents stimulate the central nervous system to release endogenous opioid peptides ( beta-endorphins and enkephalins) into the cerebrospinal fluid, elevating maternal pain tolerance.
Clinical Use and Safety
NICE NG235 advises that TENS devices are not provided by the NHS and that there is very little evidence of effectiveness in established labour , but no evidence of harm. If a woman wants to use TENS, her choice is supported and other pain relief can be used alongside it. Women who find it helpful usually start it early, in the latent phase.
The woman retains complete autonomous control of the handheld unit, adjusting the baseline pulse frequency and activating a "boost" button during contractions.
Safety & Contraindications : TENS cannot be used in water (pools, showers) and is contraindicated in women with cardiac pacemakers or implantable defibrillators.
Loading diagram... Intrapartum Analgesia Modality Comparison & Stepped Care Ladder
Pharmacological Analgesia: Inhalational & Systemic
When non-pharmacological methods do not provide sufficient comfort, or when a woman requests medical pain relief, midwives provide evidence-based pharmacological analgesia.
1. Inhalational Analgesia: Entonox
Entonox is a pre-mixed medicinal gas composed of 50% nitrous oxide ( N 2 O N_2O N 2 O ) and 50% oxygen ( O 2 O_2 O 2 ) . It is the most widely utilized pharmacological agent in UK intrapartum care.
Pharmacokinetics and Timing of Administration
Mechanism : Nitrous oxide induces analgesia and mild euphoria by stimulating the release of endogenous encephalins and modulating spinal NMDA and GABA receptors.
Onset and Peak : Inhaled Entonox diffuses rapidly across alveolar capillary membranes into the cerebral circulation. Analgesic onset occurs within 20 to 30 seconds , reaching peak concentration and maximum clinical efficacy at 45 to 60 seconds after commencing inhalation.
Clinical Coaching Technique : Because a typical labour contraction lasts 45 to 60 seconds, timing of inhalation is critical . The midwife must teach the woman to begin deep, rhythmic inhalations through the mouthpiece or mask at the very earliest warning twinge of an oncoming contraction . This ensures that the peak drug effect coincides synchronously with the acme (peak) of the contraction. The woman should stop inhaling as the contraction fades to avoid dizziness between contractions.
Autonomous Demand Valve : Entonox is self-administered using a two-stage demand valve. The woman must hold the mask or mouthpiece herself. Partners and midwives must never hold the mask for the woman . If the woman becomes drowsy, her hand naturally falls away from her face, releasing the valve, ceasing delivery, and preventing overdose.
Maternal Side Effects : Lightheadedness, dry mouth, nausea, vivid dreams, mild disorientation, and tingling sensations (paresthesia) caused by hyperventilation.
Absolute Contraindications : Nitrous oxide diffuses rapidly into closed, air-filled cavities 34 times faster than nitrogen can leave, causing rapid gas expansion. Entonox is strictly contraindicated in:
- Known or suspected pneumothorax ;
- Bowel obstruction or paralytic ileus;
- Decompression sickness (recent scuba diving within the preceding 24 hours );
- Air embolism;
Severe maxillofacial injury or fractured skull base with altered consciousness.
2. Systemic Opioids: Diamorphine and Pethidine
Intramuscular systemic opioids provide systemic analgesia, sedation, and relief from emotional distress during the active first stage of labour.
Pharmacological Profiles and Dosing
Diamorphine Hydrochloride : The opioid of choice in many UK maternity units. Highly lipophilic, diamorphine crosses the blood-brain barrier rapidly, offering superior analgesia, less emesis, and greater maternal relaxation compared to pethidine. Administered as an intramuscular dose of 5 to 10 mg (typically 7.5 mg IM).
Pethidine Hydrochloride : A synthetic opioid widely utilized across UK units. Administered as an intramuscular dose of 50 to 100 mg IM (every 2-4 hours, maximum 400 mg in 24 hours). Metabolized by the liver into norpethidine , an active toxic metabolite with a long neonatal elimination half-life (up to 60-70 hours) that exerts central neurotoxic and pro-convulsant effects.
Antiemetic Co-Administration : Opioids directly stimulate the chemoreceptor trigger zone (CTZ) in the area postrema of the medulla. An intramuscular antiemetic—most commonly cyclizine (50 mg IM) —should be prescribed and administered concurrently to prevent severe nausea and vomiting.
Maternal and Neonatal Risks
Maternal Effects : Central sedation, respiratory depression, nausea, orthostatic dizziness, and delayed gastric emptying (which heightens the risk of pulmonary aspiration [Mendelson's syndrome] should emergency general anaesthesia be required).
Fetal Effects : Opioids readily cross the placenta. Fetal heart rate monitoring frequently exhibits a temporary loss of baseline variability and absence of accelerations (a flattened CTG pattern), which typically persists for 60 to 90 minutes post-administration.
Neonatal Respiratory Depression : If an opioid is administered within 2 to 4 hours prior to delivery , the neonate is at high risk of delivery-room respiratory depression, poor muscle tone (hypotonia), hypothermia, and delayed, impaired establishment of breastfeeding.
Warning
Before administering any systemic opioid to a labouring woman, the midwife must verify that neonatal resuscitation equipment is fully functional and that neonatal naloxone (an opioid antagonist; BNFC neonatal doses are 10 micrograms/kg IV, repeated if needed, or a single 200 microgram (about 60 micrograms/kg) IM dose at birth) is immediately available in the birth room to treat acute neonatal opioid-induced respiratory depression.
Regional Analgesia: Epidural Anaesthesia
Epidural analgesia is the most effective method of intrapartum pain relief, providing complete or near-complete sensory blockade while preserving maternal consciousness.
Pharmacology and Administration
Technique : An anaesthetist introduces a Tuohy needle into the lumbar epidural space (typically at the L2-L3 or L3-L4 interspace ), passing through the ligamentum flavum. A fine polyethylene epidural catheter is threaded into the space, and the needle is removed.
Medication : Modern UK protocols utilize low-dose combined infusions consisting of a local anaesthetic (e.g., bupivacaine 0.0625% to 0.1% ) and a lipid-soluble synthetic opioid (e.g., fentanyl 2 mcg/mL or sufentanil ). This low-concentration regimen achieves effective sensory analgesia while preserving motor function ("mobile epidural"), allowing maternal leg movement.
Clinical Management Protocol and Midwifery Care
Clinical Domain Mandatory Protocol Rationale & Management
Informed Consent Prior discussion of common side effects and rare complications. Inform woman of hypotension, pruritus, prolonged second stage, severe headache after an epidural (about 1 in 100), temporary nerve damage (about 1 in 1,000) and nerve damage lasting more than 6 months (about 1 in 13,000) (OAA information).
IV Access (No Routine Preload) Always secure IV access (wide-bore cannula) before starting regional analgesia. NICE NG235 states that preloading and maintenance fluid infusion are not needed routinely before low-dose epidural or combined spinal-epidural analgesia. IV access allows rapid fluid or vasopressor treatment if sympathetic blockade causes hypotension.
Blood Pressure Surveillance Measure BP every 5 minutes for 15 minutes during establishment and after each further bolus of 10 mL or more of low-dose solution (NICE NG235), then at regular intervals per local policy. Sympathetic blockade causes acute arterial vasodilation. A drop in systolic BP > 20 % >20\% > 20% or < 100 mmHg <100\text{ mmHg} < 100 mmHg warrants immediate action.
Managing Hypotension 1. Ensure immediate left lateral tilt ; 2. Open IV crystalloid fluids wide; 3. Administer prescribed vasopressors (e.g., ephedrine 3-6 mg IV or phenylephrine 50-100 mcg IV ); 4. Call anaesthetist immediately. Restores maternal venous return and cardiac output, rapidly restoring uteroplacental blood flow to prevent fetal decelerations.
Fetal Monitoring NICE NG229 advises offering continuous CTG once regional analgesia is inserted, so monitoring normally continues while the epidural is in place. Epidural-induced maternal hypotension or rapid changes in vascular tone can cause sudden reductions in placental perfusion and fetal hypoxia.
Bladder Care Palpate the bladder every 2 hours ; perform regular intermittent catheterisation (or place an indwelling catheter). Epidural blocks sensory afferents from S2-S4, eliminating the sensation of bladder distension. A full bladder impedes fetal descent and causes uterine atony.
Positioning & Pressure Change maternal position every 1 to 2 hours (alternating left lateral, right lateral, and supported upright sitting). Prevents localized pressure sores, avoids unilateral epidural block ("patchy block"), and aids fetal descent and rotation.